Paradromics Turning Data Into Medicine
Founded 2015 Β· 14 known investors
Paradromics develops brain-computer interface (BCI) technology, building a neural implant platform intended for clinical use to help people through direct connection to the brain.
Deep TechHealthtechMedical Devices
Investors Β· 14
15th RockYokohama
Alpha EdisonLos Angeles Β· $1M β $10M
Anthropy PartnersSeattle
Capital FactoryAustin
CoastCapVienna
Frontier Path VCLondon
FusionPalo Alto Β· $500K β $1M
Kaleida CapitalSan Diego
Loup VenturesMinneapolis
Outliers Fund
Prime Movers LabJackson Β· $2M β $30M
Red Beard VenturesWestport Β· $90K β $300K
Social StartsSan Francisco
Dolby Family VenturesreportedSan Francisco
Non-dilutive funding Β· 2 SBIR/STTR awards
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $3.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $797.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Paradromics Turning Data Into Medicine do?
- Paradromics develops brain-computer interface (BCI) technology, building a neural implant platform intended for clinical use to help people through direct connection to the brain.
- Who are Paradromics Turning Data Into Medicine's investors?
- Paradromics Turning Data Into Medicine's investors include 15th Rock, Alpha Edison, Anthropy Partners, Capital Factory, CoastCap, Frontier Path VC, Fusion, Kaleida Capital and 6 more.